Many relatively young people are dying of heart attacks nowadays
This Beast of a human being died while running on the treadmill, fully vaccinated.
[MEDIA=twitter]1514117270049472513[/MEDIA]
Hii kitu haitaki vigorous exercise
Pericarditis and myocarditis.
Fully vaccinated Australia now seeing massive rise in “unexplained heart attacks”
Now that most of Australia has received all required doses of Wuhan coronavirus (COVID-19) “vaccine” as mandated by the government, the country’s hospital system is overflowing with patients suffering from a variety of health problems.
One expert revealed that there has been a 40 percent rise in “Code 1s,” as well as lots of “unexplained” heart attacks, chest pains, and respiratory ailments. The situation sounds truly dire, but nobody seems to want to identify the elephant in the room, which is the injection.
“Sometimes you can’t explain why those things happen,” said the woman in the below interview, pleading ignorance on the matter.
When asked if she has any theories or ideas as to what might be causing this, the woman responded as follows:
Tuliwaambia muwache kiherehere ya kwenda kudungwa poisonous fuck-seen
kenya tunajenga factory ya hizi vaccine buana
[SIZE=7]Covid 19: Moderna to build mRNA vaccine manufacturing facility in Kenya[/SIZE]
[ul]
[/ul]
A health official prepares a syringe with the Moderna Covid-19 vaccine prior to administering it during a mass Covid-19 vaccination drive in Nairobi on September 17, 2021. Sim -
Copyright © africanews
SIMON MAINA/AFP or licensors
By Rédaction Africanews
Last updated: 08/03 - 14:46
KENYA
Pharmaceutical giant Moderna has signed a memorandum of understanding (MOU) with Kenya’s government for its first mRNA vaccine manufacturing facility in Africa.
In a statement on Monday (07 March), the company said its goal is to produce up to 500 million doses of vaccines a year for the continent, with a focus on drug substance manufacturing, though the facility could be expanded to include fill-and-finish work.
“In parallel, Moderna is also working on plans to allow it to fill doses of its COVID-19 vaccine in Africa as early as 2023, subject to demand,” the company said.
Currently, the least vaccinated region in the world against the coronavirus, Africa relies on imports for about 99% of its vaccine needs, according to the World Health Organization.
In October, Senegal and Rwanda signed an agreement with BioNTech for the construction of its first start-to-finish factories to make mRNA vaccines in Africa.
The novel mRNA process uses the genetic code for the spike protein of the coronavirus and is thought to trigger a better immune response than traditional vaccines. Scientists hope the technology, which is easier to scale up than traditional vaccine methods, might ultimately be used to make vaccines against other diseases, including malaria.